Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hepatoblastoma × Sorafenib × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

OTHER 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 121 Liver Neoplasms 38 Leukemia, Myeloid, Acute 32 Carcinoma, Renal Cell 32 Neoplasm Metastasis 24 Breast Neoplasms 23 Carcinoma, Non-Small-Cell Lung 20 Kidney Neoplasms 16 Pancreatic Neoplasms 12 Neoplasms 12 Prostatic Neoplasms 11 Lung Neoplasms 11 Sarcoma 9 Recurrence 9 Melanoma 9 Myelodysplastic Syndromes 8 Colorectal Neoplasms 8 Brain Neoplasms 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Leukemia 6 Glioblastoma 6 Urinary Bladder Neoplasms 5 Multiple Myeloma 5 Leukemia, Myelomonocytic, Chronic 5 Thyroid Neoplasms 4 Stomach Neoplasms 4 Ovarian Neoplasms 4 Liver Diseases 4 Adenocarcinoma of Lung 4 Adenocarcinoma 4

Interventions

Cyclophosphamide 6 Granulocyte Colony-Stimulating Factor 5 Melphalan 4 Etoposide 4 Cisplatin 4 Carboplatin 4 sodium thiosulfate 3 fludarabine 3 Thiotepa 3 Mesna 3 Filgrastim 3 Busulfan 3 pembrolizumab 2 Vorinostat 2 Vincristine 2 Peripheral Blood Stem Cell Transplantation 2 Nivolumab 2 Ifosfamide 2 Gemcitabine 2 Fluorouracil 2 Doxorubicin 2 talazoparib 1 sintilimab 1 sargramostim 1 pegylated granulocyte colony-stimulating factor 1 omburtamab I-131 1 lenvatinib 1 irinotecan sucrosofate 1 fludarabine phosphate 1 etoposide phosphate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03017326 2024-05-13

PHITT

University of Birmingham

Phase 3 Active not recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡